慢性自发性疹患者的不同剂量和奥马利祖马布疗程:通过元分析和试验顺序分析进行系统审查
Haiyan Qin1, Xianjun Xiao2, Di Qin1
1Department of Acupuncture and Moxibustion, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
The World Allergy Organization journal
|April 16, 2024
概括
奥马利祖马布通过减少症状严重性和改善生活质量,有效治疗慢性自发性 (CSU). 虽然它通常是安全的,但它对血管的影响需要进一步研究.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性自发性疹 (CSU) 是一种使人虚弱的疾病.
- 在CSU中,奥马利祖马布的疗效和安全性需要全面评估.
研究的目的:
- 系统地审查和分析奥马利祖马布在CSU的疗效和安全性.
- 用试验顺序分析来评估治疗稳定性.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 试验顺序分析 (TSA) 和出版偏差评估.
- 柯克兰偏见风险工具2用于质量评估.
主要成果:
- 奥马利祖马布显著改善了疹活动评分 (UAS=0) 和减少了的严重程度 (ISS7 MID).
- 治疗在血管发炎加重的几天表现出积极效果,这得到了TSA的证实.
- 奥马利祖马布耐受性良好,没有发现任何重大安全问题.
结论:
- 奥马利祖马布,特别是300毫克为12周,是一种有效的治疗CSU.
- 需要进一步的研究来澄清奥马利祖马布对CSU患者血管的作用.
- 在CSU中血管的临床管理需要更多的关注.
更多相关视频
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
130
06:02Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
Published on: February 23, 2024
649
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
284
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
284
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K